Impact of Cardiovascular Comorbidities on the Effectiveness and Safety of Bevacizumab in Older Patients with Metastatic Colorectal Cancer.
- DOI
- 10.1007/s11523-023-00986-2
- Published
- 2023 Sep
- Container
- Targeted oncology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s11523-023-00986-2,
title = {Impact of Cardiovascular Comorbidities on the Effectiveness and Safety of Bevacizumab in Older Patients with Metastatic Colorectal Cancer.},
author = {Gouverneur A and Favary C and Jové J and Rouyer M and Bignon E and Salvo F and Tchalla A and Paillaud E and Aparicio T and Noize P},
year = {2023},
journal = {Targeted oncology},
doi = {10.1007/s11523-023-00986-2},
url = {https://doi.org/10.1007/s11523-023-00986-2}
}RIS
TY - JOUR TI - Impact of Cardiovascular Comorbidities on the Effectiveness and Safety of Bevacizumab in Older Patients with Metastatic Colorectal Cancer. AU - Gouverneur A AU - Favary C AU - Jové J AU - Rouyer M AU - Bignon E AU - Salvo F AU - Tchalla A AU - Paillaud E AU - Aparicio T AU - Noize P PY - 2023 JO - Targeted oncology DO - 10.1007/s11523-023-00986-2 UR - https://doi.org/10.1007/s11523-023-00986-2 ER -
APA
A, G., C, F., J, J., M, R., E, B., F, S., A, T., E, P., T, A., & P, N. (2023). Impact of Cardiovascular Comorbidities on the Effectiveness and Safety of Bevacizumab in Older Patients with Metastatic Colorectal Cancer.. Targeted oncology. https://doi.org/10.1007/s11523-023-00986-2
Source records
- pubmed · retrieved 2026-11-10T11:43:48.023Z